Targeting antigen-presenting cells by anti–PD-1 nanoparticles augments antitumor immunity

Recent studies in cancer research have focused intensely on the antineoplastic effects of immune checkpoint inhibitors. While the development of these inhibitors has progressed successfully, strategies to further improve their efficacy and reduce their toxicity are still needed. We hypothesized that...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Main Authors: Ordikhani, Farideh, Uehara, Mayuko, Kasinath, Vivek, Dai, Li, Eskandari, Siawosh K., Bahmani, Baharak, Yonar, Merve, Azzi, Jamil R., Haik, Yousef, Sage, Peter T., Murphy, George F., Annabi, Nasim, Schatton, Tobias, Guleria, Indira, Abdi, Reza
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Clinical Investigation 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237477/
https://ncbi.nlm.nih.gov/pubmed/30333312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122700
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares